https://rjrindex.com/articles/clinicogenomic-determinants-of-early-progression-on-first-line-osimertinib-in-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-activity-of-rem-422-a-myb-mrna-degrader-in-recurrentmetastatic-adenoid-cystic-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-c-plus-rivoceranib-r-with-transarterial-chemoembolization-tace-vs-tace-alone-in-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-the-immune-microenvironment-in-malignant-pleural-effusion-from-egfr-tki-resistant-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-the-delta-opioid-receptor-dor-on-myeloid-immunosuppressive-cells-novel-therapeutic-appr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-information-seeking-behavior-in-patients-with-cancer-through-storytelling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-iii-study-of-mrg006a-a-first-in-class-glypican-3-gpc3-targeted-antibody-dru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilocytic-astrocytoma-an-ncdb-analysis-of-contemporary-clinical-and-socioeconomic-patterns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-tarlatamab-in-small-cell-lung-cancer-and-extrapulmonary-neuroendoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-patient-reported-outcome-of-trophoblast-cell-surface-antigen-2-antibody-drug-conjugate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-assessment-of-the-meet-uro-and-imdc-scores-in-metastatic-renal-cell-carcinoma-mrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/type-2-cytokines-in-breast-epithelial-homeostasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aacr-genie-analysis-of-211526-patients-to-evaluate-hormone-receptor-alterations-across-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disruption-of-the-atad3a-vdac1-complex-to-enhance-anti-tumor-immunity-and-response-to-immune-checkpo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-crizotinib-treatment-for-alk-and-ros1-metastatic-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-becotarug-plus-osimertinib-with-a-real-world-osimertinib-therapy-cohort-in-platinum-refrac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-ultra-sensitive-wgs-based-mrd-detection-in-head-and-neck-squamous-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-zanubrutinib-in-waldenstrom-macroglobulinemia-a-systematic-review-and-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pretreatment-ct-based-radiomics-and-machine-learning-models-for-predicting-treatment-response-in-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-profile-of-nanoliposomal-irinotecan-fluorouracil-and-leucovorin-nal-iri5-fulv-in-gemc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-predictors-of-postoperative-seizure-outcomes-in-adult-low-grade-glioma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-deep-learning-approach-to-quantitatively-capture-cerebellar-overgrowth-in-pediatric-nf1-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-capivasertib-based-combination-therapy-in-pten-deficient-advanced-or-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-patterns-and-disparities-in-supportive-oncology-services-for-patients-with-stage-iv-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-deep-learning-approach-to-quantify-tumor-microenvironment-features-associated-with-postoperative-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-histone-h3-lysine-18-lactylation-for-the-prediction-of-immunotherapy-efficacy-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-landscape-of-met-alterations-in-non-small-cell-lung-cancer-in-southeast-china-a-real-world-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/apalutamide-in-chinese-patients-with-metastatic-hormone-sensitive-prostate-cancer-mhspc-final-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-prior-prostate-cancer-screening-with-stage-at-diagnosis-in-a-us-ehr-cohort-2018-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-analysis-of-cardiovascular-complications-in-her2-positive-breast-cancer-patients-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-eight-treatments-for-metastatic-hormone-sensitive-prostate-cancer-mh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pleural-effusion-on-mortality-and-hospitalization-in-stage-iv-iegfr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/young-breast-cancer-patients-and-molecular-reclassification-using-rna-sequencing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-darolutamide-plus-androgen-deprivation-therapy-in-de-novo-metastatic-hormone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-camrelizumab-plus-apatinib-and-temozolomide-for-resectable-stage-iii-acral-melanoma-upd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characterization-of-sez6-a-transmembrane-protein-expressed-in-various-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-the-decentralized-msk-access-powered-with-sophia-ddm-liquid-biopsy-assay-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/what-do-patients-undergoing-androgen-deprivation-therapy-think-about-exercise-interventions-and-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-survival-outcomes-in-ialki-fusion-positiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spevatamig-pt886-a-claudin-182-cldn182cd47-bispecific-antibody-in-combination-with-gemcitab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-remote-symptom-monitoring-program-on-payor-specific-healthcare-costs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-development-and-validation-of-the-lung-cancer-prevention-score-lcps-a-quantitative-framewo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-kidney-cancer-using-blood-based-multi-gene-mrna-profiling-in-a-prospective-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-taxane-mrna-based-profile-in-neoadjuvant-therapy-across-i-spy2-investigational-arms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-hoc-efficacy-and-biomarker-analysis-of-elraglusib-plus-gemcitabinenab-paclitaxel-versus-chemot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nodulomics-histopathologic-and-genomic-heterogeneity-among-multiple-malignant-pulmonary-nodules-sam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/penpulimab-pd-1-inhibitor-combined-with-platinum-based-chemotherapy-as-induction-therapy-for-newly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-free-survival-tfs-in-patients-with-advanced-urothelial-carcinoma-auc-treated-with-enfo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-prognostic-risk-stratification-of-neoadjuvant-immunotherapy-for-stage-iii-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-determinants-of-end-of-life-care-settings-and-place-of-death-among-patients-with-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-icdh1i-germline-variants-in-gastric-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-food-access-and-poverty-on-somatic-genomic-profiles-and-clinical-outcomes-in-metastatic-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-toxicity-in-patients-with-advanced-pancreatic-cancer-in-mexico 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-a-temperature-controlled-oral-cryotherapy-device-in-preventing-oral-mucositis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-binimetinib-in-combination-with-encorafenib-in-patients-with-pancreatic-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mammography-utilization-and-male-breast-cancer-in-brca12-carriers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ifbxw7i-mutation-with-prolonged-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-for-advanced-cancer-medicare-advantage-and-provider-networks 2026-08-24 monthly 0.7 https://rjrindex.com/articles/denosumab-versus-zoledronic-acid-in-patients-with-breast-cancer-a-propensity-matched-real-world-tim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rw-post-progression-outcomes-following-first-line-1l-ribociclib-rib-aromatase-inhibitor-ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/county-level-palliative-care-physician-density-and-socioeconomic-determinants-of-place-of-cancer-dea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isatuximab-plus-pomalidomide-dexamethasone-in-relapsedrefractory-multiple-myeloma-subgroup-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-university-of-texas-cancer-cachexia-staging-utccs-with-clinical-variables-of-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-oncology-clinical-trial-complexity-and-duration-a-retrospective-analysis-of-526 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-satricabtagene-autoleucel-satri-cel-as-sequential-therapy-after-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/score-evaluation-and-prevalence-of-her2-status-in-pleural-mesothelioma-pm-mesoher-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dysphagia-associated-inpatient-risk-phenotypes-and-mortality-in-hospitalized-head-and-neck-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-t-cell-lag-3-expression-and-clinical-benefit-in-patients-with-type-2-diabetes-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatectomy-with-and-without-preoperative-biliary-drainage-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-into-the-impact-of-base-excision-repair-genes-on-immunotherapy-response-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/th1th2-immune-polarization-and-cancer-of-unknown-primary-cup-risk-in-autoimmune-disease-a-global 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-of-adenoid-cystic-carcinoma-using-the-aacr-genie-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-pancreatic-cancer-in-elderly-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-and-respiratory-outcomes-in-cancer-patients-with-pre-existing-asthma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progress-tracker-breast-cancer-registry-reporting-worry-of-illness-from-a-longitudinal-peer-led-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/projecting-2050-oncology-workforce-through-historical-regional-trends-and-economic-stratification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimating-survival-in-advanced-cancer-a-prospective-single-center-study-on-the-accuracy-of-oncolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-center-retrospective-analysis-of-neoadjuvant-therapy-in-resectable-pancreatic-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cxcr2-expression-in-lung-neuroendocrine-neoplasms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relative-benefit-of-perioperative-chemotherapy-after-resection-for-stage-iii-colon-cancer-in-the-70s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accessibility-of-study-contact-information-in-clinicaltrialsgov-a-comprehensive-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-effects-of-usp10-on-pancreatic-ductal-adenocarcinoma-metastasis-via-deubiquitinating-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-pancreatic-cancer-in-the-asia-pacific-region-incidence-mortality-and-modifiable-risk-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-gastrointestinal-cancer-patients-with-targetable-genomic-alterations-identifi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shared-and-distinct-molecular-signatures-of-resistance-to-different-endocrine-therapies-alliance-a0 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-ctdna-kinetics-and-overall-survival-in-patients-with-urothelial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-in-patients-with-her2-expressing-locally-advanced-or-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pregnancy-outcomes-in-women-with-myeloproliferative-neoplasms-a-multicenter-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/msnpseq-an-ngs-based-assay-for-chimerism-detection-and-risk-assessment-in-allogeneic-hsct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-her-family-expression-and-clinical-outcomes-with-trastuzumab-deruxtecan-t-dxd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-regorafenib-treatment-on-overall-survival-os-in-advanced-sarcoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-pathology-biomarkers-for-platinum-resistance-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/golcadomide-golca-a-potential-first-in-class-oral-celmod-pola-rchp-in-patients-pts-with-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/direct-oral-anticoagulants-versus-low-molecular-weight-heparin-in-patients-with-liver-metastases-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-mortality-and-hospitalization-following-cholangiocarcinoma-diagnosis-by-statin-exposure-a-tri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-future-mortality-trends-in-multiple-myeloma-seer-analysis-2000-2030 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-of-laparoscopic-hybrid-surgery-versus-total-open-surgery-for-simultaneous-resectio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-type-and-location-of-ibrca2i-deleterious-vari 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-population-based-testing-for-pathogenic-variants-in-breast-cancer-genes-on-screening-recom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-the-receipt-of-recommended-cardiovascular-assessment-among-cancer-survivors-in-the-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-patients-with-human-epidermal-growth-factor-receptor-2-her2-low-and-ultralow-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-corticosteroid-dosing-after-anti-cd19-car-t-therapy-for-large-b-cell-lymphoma-multicenter-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-circulating-tumor-dna-ctdna-for-recurrence-detection-across-solid-tumors-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-according-to-ramucirumab-ram-related-hypertension-htn-in-patients-pts-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivonescimab-ivo-with-oxaliplatin-fluorouracil-5-fu-leucovorin-calcium-mfolfox6-for-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-based-total-neoadjuvant-therapy-with-or-without-short-course-radiotherapy-for-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlative-analysis-of-ctdna-in-checkmate-9x8-study-of-frontline-treatment-with-mfolfox6-bevacizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-asciminib-in-veterans-with-chronic-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-powered-spatial-analysis-of-endothelial-cells-and-tumor-infiltrating-lymphoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-fracture-burden-of-osteoporosis-among-patients-with-colorectal-cancer-a-real-world-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-anti-pd-1-monoclonal-antibody-and-folfoxiri-combined-with-long-course-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-tislelizumab-plus-oxaliplatin-and-s-1-for-locally-advanced-siewert-type-ii-esophagogastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-financial-burden-of-who-defined-disability-among-childhood-cancer-survivors-a-report 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-study-of-pembrolizumab-plus-lenvatinib-or-pembrolizumab-coformulated-with-vibostolimab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-matters-association-of-mfi-5-index-with-odds-of-mortality-hospitalization-and-toxicities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/llm-generated-serious-illness-conversation-summaries-to-improve-care-for-hospitalized-patients-a-pi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/environmental-exposure-and-prevalence-of-papillary-thyroid-cancer-in-west-virginia-an-ecological-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-and-prognostic-performance-of-a-14-gene-molecular-risk-assay-in-stage-ia-iia-non-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-iberdomide-daratumumab-bortezomib-and-dexamethasone-in-patients-with-newly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onsite-serial-monitoring-of-high-grade-serous-ovarian-cancer-hgsoc-mutations-in-circulating-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-endocrine-therapy-and-cognitive-impairment-in-long-term-breast-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficiency-of-remote-symptom-monitoring-using-electronic-patient-reported-outcome-epro-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-and-nonconcordance-with-endocrine-and-her2-therapy-for-breast-cancer-a-sequentia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-risk-prediction-model-for-severe-life-threatening-and-fatal-treatment-related-toxicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-of-ak130-tigittgf-v-bispecific-fusion-protein-combined-with-ivonescimab-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-radical-surgery-versus-concurrent-chemoradiotherapy-in-stage-ib3-iia2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folfoxiribevacizumab-in-microsatellite-stable-pmmrmss-irasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-circulating-protein-biomarkers-of-second-line-aflibercept-plus-folfiri-according-to-pri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-pertuzumab-biosimilar-bcd-178-versus-the-originator-pertuzumab-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-to-rescue-after-major-complications-in-endometrial-cancer-a-national-inpatient-analysis-ni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-dyslipidemia-in-treatment-naive-breast-cancer-molecular-subtype-specific-patterns-in-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-deep-learning-model-for-immunotherapy-efficacy-prediction-directly-from-hampe-slides-in-head-nec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-indoor-and-outdoor-air-pollution-worry-and-awareness-and-acceptability-of-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telemedicine-in-oncology-impact-on-clinical-outcomes-access-to-care-and-future-oncology-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/designing-a-solid-tumor-oncology-curriculum-for-medical-residents-a-single-institution-needs-assess 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-combined-with-bevacizumab-and-trifluridinetipiracil-as-third-line-or-later-therapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-computed-tomography-scans-and-lung-cancer-development-in-patients-with-pulmonary-symp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-phenotype-at-diagnosis-for-prediction-of-survival-in-de-novo-stage-iv-neuroendocrine-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-spatial-tumor-architecture-and-ecm-recapitulation-using-an-eo771-syngeneic-tnbc-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-metal-ion-transport-in-pancreatic-cancer-a-prognostic-signature-and-graphban-predicted-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-cetuximab-plus-chemotherapy-as-first-line-treatment-of-recurrent-andor-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-ireti-variants-in-medullary-thyroid-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-characteristics-and-cancer-specific-survival-in-adolescents-and-young-adults-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-trends-in-pheochromocytoma-in-the-united-states-1975-2022-a-seer-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-expression-heterogeneity-ihcfish-in-breast-cancer-a-systematic-review-and-meta-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spectrum-of-autosomal-recessive-pediatric-cancer-predisposition-syndromes-in-a-population-with-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emergency-vs-elective-presentation-as-a-care-delivery-phenotype-in-presumed-early-stage-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-disease-management-among-patients-with-multiple-myeloma-and-their-care-partners 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-approach-to-improving-clinical-trial-referral-and-enrollment-for-patients-with-cancer-a-cro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-killer-cell-immunoglobulin-like-receptor-kir-polymorphisms-and-their-hla-ligands-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-bdc-4182-a-claudin-182-targeting-next-generation-immune-stimulating-antibody 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-dv-combined-with-trastuzumab-and-tislelizumab-versus-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-trial-investigating-platinum-and-taxane-chemotherapy-in-metastatic-castration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alpacca-phase-3-trial-of-firmonertinib-vs-investigators-choice-of-egfr-inhibitor-as-first-line-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-hydroxymethylglutaryl-coa-synthase-2-hmgcs2-expression-and-survival-in-patients-with-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-burden-and-outcomes-of-car-t-therapy-toxicities-in-dlbcl-multiple-myeloma-and-b-all-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-and-outcomes-among-hospitalized-cancer-patients-with-severe-non-cancer-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-hoxb7-on-oxaliplatin-resistance-in-colon-cancer-through-glutamine-metabolic-reprogramming 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-inpatient-outcomes-of-invasive-aspergillosis-in-hospitalizations-with-hematologi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/febrile-neutropenia-prophylaxis-with-prolonged-g-csf-in-elderly-cancer-patients-analysis-from-the-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-burden-of-cardiomyopathy-deaths-among-united-states-cancer-patients-a-25-year-cdc-wonder-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-transfusion-timing-on-clinical-outcomes-across-hematologic-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/capela-a-phase-ii-multicenter-open-label-randomized-study-of-capecitabine-in-combination-with-elace 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-scalable-psychosocial-interventions-to-address-patient-identified-needs-in-hereditary-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-cellular-locality-vision-transformer-based-modeling-for-diagnosis-and-classification-of-bloo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patent-claim-landscape-of-fda-orange-book-listed-oral-oncology-drugs-a-systematic-analysis-of-stand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-mindfulness-psychological-distress-and-coping-among-hematopoietic-stem-cell-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/septicemia-in-acute-lymphoblastic-leukemia-disparities-in-incidence-resource-utilization-and-mort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-vulnerability-index-as-an-independent-poor-prognostic-factor-in-patients-with-chronic-hematol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extracellular-and-immune-matrix-signature-of-interstitial-fluid-as-mediator-of-pathological-characte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-agent-ai-system-integrating-real-world-data-and-competitive-intelligence-to-generate-automat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-screening-practices-among-head-and-neck-cancer-survivors-in-us-veterans-a-pilot-surve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-demographic-disparities-in-mortality-among-adults-with-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-car-t-safety-in-the-united-states-severe-icans-and-crs-by-donor-source-and-antigen-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-risk-factors-and-treatment-preferences-for-patients-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camperr-a-multicenter-prospective-observational-study-to-evaluate-a-cfdna-based-genome-wide-methy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-eligibility-criteria-in-solid-tumor-systemic-therapy-trials-over-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cocaine-use-disorder-among-hospitalized-patients-with-non-hodgkins-lymphoma-a-national-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/practice-disparities-in-palliative-care-utilization-across-different-solid-malignancies-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-sponsor-held-platform-ind-model-for-personalized-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-mtor-pathway-mutations-on-response-to-mtor-inhibition-in-neuroendocrine-neoplasms-nens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-incidence-and-mortality-among-us-young-adults-younger-than-50-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/asciminib-in-newly-diagnosed-philadelphia-chromosom-positive-chronic-myeloid-leukemia-in-chronic-pha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/length-of-stay-costs-and-mortality-in-colon-cancer-a-regional-comparison-between-the-northeast-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tace-combined-with-immune-checkpoint-inhibitors-and-vegf-inhibitors-in-hepato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemotherapy-versus-chemoradiotherapy-in-high-risk-extrahepatic-cholangiocarcinoma-and-gall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-masld-in-hospital-mortality-in-patients-with-cholangiocarcinoma-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/where-climate-hits-hardest-geographic-patterns-in-climate-education-across-266-us-oncology-fellow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indirect-treatment-comparison-of-cabozantinib-vs-sunitinib-in-the-treatment-of-pancreatic-neuroendoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-study-comparing-telisotuzumab-adizutecan-monotherapy-with-standard-of-care-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-ivosidenib-post-first-line-immunotherapy-in-biliary-tract-cancer-a-real-world-matched-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exercise-therapy-in-survivors-of-gastroesophageal-cancer-a-phase-i-randomized-dose-finding-study-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/encyclopedic-tumor-analysis-guided-therapy-in-refractory-advanced-cancers-clinical-and-health-econo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-use-among-locally-advanced-cervical-cancer-patients-lacc-in-the-united-states-communi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-dependent-patterns-of-immune-related-adverse-events-by-obesity-status-following-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-her2-paradox-in-ovarian-clear-cell-carcinoma-expression-and-intrinsic-resistance-to-trastuzumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-red-blood-cell-dna-for-early-detection-of-advanced-colorectal-neoplasia-a-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eiu-104101-a-first-in-human-phase-1a1b-study-of-evolve104-a-trispecific-cd3cd2ulbp256-t-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-assisted-survival-prediction-in-glioma-meta-analysis-of-prospective-and-controlled-studies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-tumor-informed-and-tumor-agnostic-ctdna-molecular-residual-disease-mrd-assessment-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-elinzanetant-on-sleep-disturbance-and-aspects-of-quality-of-life-in-women-with-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ono-4578-combined-with-nivolumab-nivo-and-chemotherapy-chemo-as-first-line-1l-treatment-for-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/napistar-1-01-results-of-phase-1-dose-escalation-of-monotherapy-with-tub-040-a-novel-napi2b-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-yl201-an-anti-b7h3-antibody-drug-conjugate-adc-in-patients-with-relapsed-or-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rally-mf-initial-efficacy-of-a-phase-2-study-of-disc-0974-an-anti-hemojuvelin-antibody-to-treat-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-results-of-the-phase-3-peak-study-of-bezuclastinib-sunitinib-vs-sunitinib-monotherapy-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-ibii-trial-of-azacitidine-venetoclax-and-ivosidenib-in-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-ra-for-primary-prevention-of-post-mastectomy-lymphedema-in-breast-cancer-patients-a-multicent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-glp1-receptor-agonists-on-survival-of-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-btk-inhibition-into-r-da-epoch-for-hiv-related-dlbcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-metastatic-castration-resistant-prostate-cancer-using-regulatory-network-analysis-of-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-in-biomarkers-for-advanced-gastric-cancer-gastroesophageal-junction-cancer-and-esoph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/window-of-opportunity-study-of-the-notch-inhibitor-al101-in-notch1-activated-adenoid-cystic-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-axillary-response-in-5262-patients-with-node-positive-breast-cancer-treated-with-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-molecular-subtyping-and-immune-profiling-to-predict-pathologic-complete-response-in-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-recurrence-or-treatment-effect-large-multi-institutional-evaluation-of-an-ai-risk-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-long-term-persistence-and-phenotypic-features-of-bcma-car-t-cells-in-patients-with-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-safety-of-intratumoral-long-acting-cisplatin-srgel-tumocure-in-refractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lorlatinib-vs-crizotinib-as-first-line-treatment-for-advanced-ialki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlative-analysis-of-phase-ii-trial-of-olaparib-and-durvalumab-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-by-tumor-location-in-the-phase-3-panova-3-trial-of-tumor-treating-fields-ttfiel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metabolic-signatures-of-response-2-hydroxybutyric-acid-as-a-biomarker-in-melanoma-patients-receivin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-clearance-after-immune-checkpoint-inhibition-ici-with-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-in-patients-pts-with-iher2i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ret-fusion-positive-lung-adenocarcinoma-partner-specific-clinicopathological-characteristics-co-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cabozantinib-plus-nivolumab-cn-versus-sunitinib-s-in-patients-with-advanced-renal-cell-carcinom-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-surgical-management-and-outcome-of-1113-patients-with-stage-i-ii-non-small-cell-lung-cancer-ns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-panel-based-next-generation-sequencing-in-a-real-world-cohort-of-neuroblastoma-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-immune-architecture-as-used-to-define-progression-and-treatment-response-in-penile-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-germline-ibrcai-pathogenic-or-likely-pathogen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durable-clinical-benefit-with-b-cell-maturation-antigen-bcma-directed-therapy-belantamab-mafodoti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-response-to-sup177sup-lu-psma-617-in-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deciphering-the-heterogeneity-and-cellular-interactions-of-cancer-associated-fibroblasts-in-extrahep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-microsatellite-stable-lynch-syndrome-and-universal-germline-testing-a-pan-cancer-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-disparities-in-early-onset-colorectal-cancer-mortality-a-national-county-level-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-metastatic-breast-cancer-mbc-bone-lesions-and-sresfractures-via-a-single-intratumoral 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ai-augmented-histopathology-review-on-next-generation-sequencing-ngs-success 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extrapulmonary-small-cell-carcinoma-treated-with-conventional-or-tumor-targeted-topoisomerase-i-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-induction-immunochemotherapy-before-concurrent-chemoradiotherapy-on-outcomes-in-limited-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-experiences-with-ugn-102-for-recurrent-low-grade-intermediate-risk-non-muscle-invasive-bladd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-ii-exploratory-clinical-study-on-the-efficacy-and-safety-of-neoadju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mrna-based-profile-to-predict-platin-sensitivity-in-nsclc-assessed-by-nanostring-a-translational-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synthetic-lethality-informed-neoantigen-prioritisation-to-support-mechanism-specific-therapeutic-str 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ilf2-as-a-predictor-of-cisplatin-resistance-and-clinical-outcomes-in-intrahepatic-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-upfront-dual-immunotherapy-on-overall-survival-in-patients-with-metastatic-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/negative-hyperselection-as-a-predictive-biomarker-of-benefit-from-first-line-doublets-anti-egfrsb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-quality-of-life-outcomes-of-177lu-psma-617-in-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-cachexia-staging-as-a-predictor-of-treatment-receipt-and-survival-in-pancreatic-ductal-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iberdomide-iber-maintenance-following-upfront-autologous-stem-cell-transplant-asct-in-multiple-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimization-of-immunotherapy-duration-for-advanced-melanoma-the-prospective-otimas-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/p53-r248q-upregulation-of-vtcn1-via-dual-mechanisms-as-a-driver-of-immune-evasion-and-adaptive-resis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-infectious-complications-and-ivig-utilization-after-teclistamab-in-relapsedrefractory-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-daratumumab-in-light-chain-amyloidosis-patients-with-advanced-renal-failure 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-dynamics-as-early-biomarkers-of-response-to-enfortumab-vedotin-plus-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-novel-bispecific-epitope-anti-cd5-nanobody-car-t-cells-for-refractory-or-relapsed-t-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-cancer-admitted-to-a-dedicated-oncology-service-within-a-multisite-home-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefit-of-adjuvant-chemotherapy-in-resected-stage-i-iv-crc-patients-based-on-ctdna-dynamics-across 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-for-patients-with-pre-treated-platinum-resistant-ovarian-cancer-receiving-gotistoba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-use-among-women-lt-50-years-with-hormone-receptor-positive-breast-cancer-with-low-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/platinum-based-chemotherapy-in-early-stage-high-risk-triple-negative-breast-cancer-a-systematic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-trial-of-folate-receptor-alpha-peptide-vaccine-in-early-stage-triple-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-utilization-of-genomic-risk-assays-in-early-stage-hormone-positive-breast-cancer-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-creating-patient-partnership-within-a-national-cancer-trials-network-experience-from-cancer-tria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-pirfenidone-on-checkpoint-inhibitor-pneumonitis-and-antitumor-efficacy-in-nsclc-a-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-failure-and-efficacy-for-unresectable-or-recurrent-gastric-and-gastroesophageal-junction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/robot-assisted-versus-laparoscopic-radical-nephrectomy-for-renal-tumors-in-adults-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-independent-antitumor-and-pharmacodynamic-responses-to-trastuzumab-deruxtecan-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-stk11-alterations-with-overall-survival-after-immune-checkpoint-inhibitor-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-immunotherapy-following-upfront-surgery-for-stage-ii-iii-triple-negative-breast-cancer-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tuning-car-t-cell-response-with-itnfaip3i-variants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-risk-of-hyperglycemia-with-pi3k-inhibitors-in-cancer-patients-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-whole-transcriptome-sequencing-for-fusion-detection-in-advanced-solid-tumors-sc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-pharmacokinetics-pk-pharmacodynamics-pd-and-antitumor-activities-of-fl115-a-novel-il 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-assessment-of-tumor-infiltrating-lymphocytes-tils-in-patients-with-triple-negative-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-clinical-characterization-of-estrogen-receptor-positiveher2-negative-early-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptome-to-identify-biomarkers-for-endocrine-sensitivity-of-hormone-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup68sup-ga-nodaga-sna014-whole-body-pet-imaging-to-detect-claudin182-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-ai-based-transcriptional-surrogate-for-epigenetic-aging-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-ratio-of-levels-of-insulin-signaling-system-factors-and-diabetes-markers-in-the-blood-of-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-177lu-psma-617-in-metastatic-castration-resistant-prostate-cancer-mcrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-microbiome-and-responders-to-immunotherapy-for-biochemically-recurrent-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-irae-and-survival-in-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tracking-genomic-evolution-in-ierbb2i-altered-biliary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/equity-in-breast-cancer-research-authorship-country-gender-and-income-representation-in-phase-iii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-small-extracellular-vesicle-micrornas-as-non-invasive-biomarkers-for-the-diagnosis-of-pancrea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ilcness-to-stratify-lobular-like-breast-cancer-biology-and-as-an-outcome-independent-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/earlier-crs-identification-with-continuous-wearable-monitoring-in-outpatient-car-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-associations-with-chemotherapy-induced-nausea-and-vomiting-a-genome-wide-association-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/micrornas-as-surrogate-biomarkers-of-future-endometrial-malignancy-in-women-with-endometrial-hyperpl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-symptom-burden-psychological-distress-and-treatment-accessibility-on-quality-of-life-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-assessment-of-cachexia-body-composition-and-patient-reported-outcomes-in-unplanned-hosp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/travel-time-to-cancer-care-as-it-relates-to-care-access-transportation-distress-and-financial-toxi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-chemotherapy-benefit-in-premenopausal-women-with-intermediate-genomic-scores-using-deep-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibacteroides-sp-dh3716pi-and-mediation-of-immunotherapy-response-in-oligom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-cardiovascular-outcomes-in-patients-with-prostate-cancer-treated-with-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-sequential-treatment-of-percutaneous-hepatic-perfusion-with-melphalanhepatic-delivery-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-survival-outcomes-in-splenic-marginal-zone-lymphoma-a-seer-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-treatment-initiation-tti-and-survival-outcomes-in-metastatic-extrapulmonary-neuroendocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-study-of-revumenib-in-combination-with-intensive-chemotherapy-in-patients-with-newly-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemo-immunotherapy-and-surgical-resection-in-locally-advanced-non-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-pembrolizumab-plus-lenvatinib-as-first-line-therapy-in-non-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scalable-knowledge-distillation-for-pancreatic-cancer-diagnosis-real-time-resnet-based-stage-strati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-reliability-of-large-language-models-for-patient-queries-concordance-with-nccn-invasive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-single-arm-open-label-multicenter-phase-2-study-of-the-radiopharmaceutical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-metastatic-phenotypes-at-diagnosis-in-prostate-cancer-a-population-based-analysis-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-double-blind-randomized-prospective-placebo-controlled-study-of-nano2-combined-with-rad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/testicular-plasmacytoma-a-comprehensive-case-series-and-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-study-of-cd34-selected-cd19-directed-car-t-with-metabolic-programming-in-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carcinoma-with-osteoclast-like-giant-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-extracellular-vesicles-carrying-pd-1-pd-l1-and-ctla-4-to-inform-resistance-to-immunoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-patient-self-management-in-hepatocellular-carcinoma-using-care-sequence-plans-a-comparati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-patterns-of-basosquamous-carcinoma-an-ncdb-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-cystineglutamate-transporter-slc7a11-in-breast-cancer-brain-metastatic-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-of-cancer-prevalence-in-young-adults-in-the-post-covid-19-era-a-multicenter-real-worl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standardizing-patient-initiated-electronic-messaging-in-a-high-volume-breast-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncertainty-aware-multimodal-imaging-for-lung-metastasis-risk-stratification-in-extremity-soft-tissu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-neoadjuvant-therapy-with-perineural-invasion-and-postoperative-survival-in-locally-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-diagnostic-delay-and-treatment-abandonment-in-advanced-lung-cancer-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-management-and-survival-in-pelvic-osteosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-lower-endoscopic-surveillance-in-high-risk-colorectal-cancer-populations-a-meta-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/descriptive-comparison-of-primary-debulking-surgery-pds-act-versus-neoadjuvant-chemotherapy-with-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-tarlatamab-across-small-cell-carcinoma-subtypes-including-transformed-and-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-pathogenic-variants-in-early-onset-colorectal-cancer-and-limitations-of-tumor-based-screeni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-eribulin-sequencing-and-outcomes-in-advanced-breast-cancer-an-lmic-cohort-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/where-do-adults-with-pancreatic-cancer-die-in-the-united-states-a-retrospective-analysis-of-25-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/when-to-begin-a-chart-based-review-of-advanced-care-planning-in-cancer-patients-one-year-prior-to-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-context-as-a-modulator-of-msi-high-and-tmb-high-as-predictors-of-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-and-care-access-barriers-among-adolescent-and-young-adult-versus-older-melanoma-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-evaluating-treatment-discontinuation-of-dual-anti-her2-therapy-in-metastatic-her2-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-prophylactic-g-csf-use-with-survival-outcomes-in-patients-with-aggressive-b-cell-lymp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-the-novel-werner-helicase-inhibitor-eik1005-as-monotherapy-and-in-combination-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-of-polq-inhibitor-syn818-combined-with-olaparib-in-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-organoids-to-predict-efficacy-of-adjuvant-treatment-to-improve-outcome-in-resectable-pancreati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-checkpoint-inhibitors-icis-in-locoregionally-advanced-nasopharyngeal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-treatment-response-and-survival-outcomes-in-plasmablastic-lymphoma-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-and-outcomes-of-cancer-related-distress-assessed-by-the-nccn-distress-thermomete 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-implications-of-hpv-related-nasopharyngeal-carcinoma-in-non-endemic-regions-a-meta-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-pd-1pd-l1-inhibitor-plus-chemotherapy-versus-chemotherapy-alone-in-esophagea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-stroke-mortality-among-gastric-cancer-patients-in-the-united-states-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-all-patients-really-need-hormonal-screening-before-an-adrenal-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-and-meta-analysis-of-cardioprotective-effects-of-sglt2-inhibitors-compared-to-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atrial-fibrillation-as-an-acute-severity-amplifier-during-cancer-hospitalizations-a-national-inpati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-variation-in-intracoronary-imaging-utilization-among-patients-with-active-malignanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iiiii-trial-of-intraperitoneal-paclitaxel-plus-systemic-treatment-vs-systemic-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-positive-central-nervous-system-cns-surveillance-a-study-of-the-feasibility-of-randomizing-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-to-evaluate-azd9750-a-novel-androgen-receptor-proteolysis-targeting-chimera-alone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nintedanib-in-advanced-solid-tumors-a-meta-analysis-of-randomized-controlled-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/miconazole-as-a-repurposed-therapeutic-candidate-for-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-volume-patient-navigator-encounters-and-access-to-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-plus-sintilimab-and-lenvatinib-for-second-line-advanced-her2-negative-gastricg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-radiation-therapy-for-peripheral-joint-osteoarthritis-early-us-community-experience-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-colorectal-cancer-trends-and-risk-exposures-in-ghana-and-the-united-states-a-comparativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-early-onset-colorectal-cancer-incidence-2000-2022-among-black-americans-and-sub-saharan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neurocognitive-outcomes-after-proton-versus-photon-radiotherapy-in-pediatric-cns-tumors-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-demographics-and-germline-mutation-patterns-across-breast-cancer-molecular-subtypes-in-a-ter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-prostate-specific-antigen-levels-for-early-detection-of-prostate-cancer-in-sub-saharan-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aromatase-independent-estradiol-synthesis-in-triple-negative-breast-cancer-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-and-nutrition-interventions-among-referrals-to-outpatient-registered-dietiti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinician-facilitated-cascade-genetic-testing-among-first-second-and-third-degree-relatives 2026-08-24 monthly 0.7 https://rjrindex.com/articles/restrictive-trial-eligibility-criteria-as-a-barrier-to-clinical-trial-enrollment-among-veterans-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-outreach-and-fecal-immunochemical-testing-fit-completion-among-vulnerable-rhode-island-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibii-clinical-study-of-adebrelimab-in-combination-with-capecitabine-and-oxaliplatin-for-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-combined-with-anti-pd-1pd-l1-antibody-in-the-second-line-or-monotherapy-in-third-line-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-quad-shot-radiation-therapy-in-combination-with-low-dose-systemic-treatment-in-advanced-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-national-cancer-policy-among-low-income-low-middle-income-and-high-middle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-involving-esophageal-cancer-and-alcohol-related-behavioral-disorders-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-study-genomic-survival-modeling-and-gene-panel-recalibration-across-heterogeneous-cohorts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-clinical-characteristics-outcomes-and-prognostic-factors-in-melanoma-a-retrospective-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-cervical-cancer-screening-awareness-and-community-identified-barriers-to-prevention-in-peo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-novel-agents-versus-standard-chemotherapy-in-first-line-1l-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-associated-type-2-versus-type-1-myocardial-infarction-a-physiology-driven-framework-for-inpa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pyrotinib-versus-pertuzumab-plus-trastuzumab-and-taxane-as-first-line-therapy-for-her2-positive-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-patients-pts-with-metastatic-breast-cancer-mbc-treated-with-trastuzumab-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-burden-among-young-adults-in-brazil-incidence-stage-at-diagnosis-and-sociodemographic-shif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/narcolepsy-and-skin-cancer-risk-inverse-comorbidity-and-the-protective-role-of-orexin-deficiency 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-resource-utilization-of-sepsis-in-hospitalized-patients-with-hematologic-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-in-chronic-lymphocytic-leukemia-patients-with-and-without-myasthenia-gravis-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-outcomes-in-metastatic-solid-tumors-harboring-alterations-in-the-pi3k-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-performance-and-readiness-of-artificial-intelligence-models-for-predicting-immune-related-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-the-characteristics-of-the-immune-microenvironment-of-patients-with-11q13-gene-amplification-reve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tace-with-or-without-mwa-followed-by-sequential-targeted-and-immunotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/update-results-of-benmelstobart-ben-combined-with-concurrent-chemoradiotherapy-ccrt-versus-ccrt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-determinants-of-cancer-risk-healthcare-violence-mental-health-and-cancer-related-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-recombinant-human-thrombopoietin-rhtpo-for-thrombocytopenia-induced-by-comb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-randomized-placebo-controlled-phase-2b-trial-of-survaxm-plus-adjuvant-temozolomide-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-study-of-a-prototype-daataa-vaccine-targeting-muc1-for-immune-interception-and-preventio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-real-world-safety-outcomes-of-pola-r-chp-versus-r-chop-in-high-grade-diffuse-large-b-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-risk-of-anemia-and-iron-deficiency-anemia-in-premenopausal-women-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-sonrotoclax-vs-pirtobrutinib-in-post-bruton-tyrosine-kinase-inhibitor-btki-relapsedre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/late-stage-prostate-cancer-in-syria-a-call-for-decentralized-and-early-detection-systems 2026-08-24 monthly 0.7 https://rjrindex.com/articles/testing-treatment-and-teamwork-differential-learning-curves-and-translational-barriers-in-egfr-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-impact-of-prophylactic-oophorectomy-in-colorectal-cancer-surgery-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-characterization-and-predictive-implications-of-the-tumor-immune-microenvironment-in-stage-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urokinase-gene-knockout-and-melanoma-mitochondria-association-with-free-radical-oxidation-processes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-ctr1-expression-and-longitudinal-serum-copper-assessment-in-breast-cancer-patients-treated-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/closing-the-gap-in-her2-testing-cep17-low-fish-results-and-ngs-discordance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tucatinib-tuc-combined-with-trastuzumab-and-pertuzumab-hp-as-first-line-1l-maintenance-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emitt-1-clinical-and-pharmacodynamic-activity-with-the-oral-erap1-inhibitor-grwd5769-and-cemiplimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-in-invasive-lobular-versus-ductal-breast-carcinoma-a-real-world-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rt01-a-first-in-class-theranostic-radionuclide-drug-conjugate-rdc-with-zirconium-89-and-lutetium 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-residency-career-intentions-among-oncology-and-related-specialty-residents-in-armenia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-estrogen-receptor-status-with-survival-outcomes-in-neuroendocrine-carcinoma-of-the-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-cancer-therapy-related-cardiotoxicity-on-oncologic-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-analysis-in-latino-young-adults-with-early-onset-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-pulmonary-embolism-in-hospitalized-patients-with-breast-cancer-a-national-inpati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-multiple-myeloma-and-antecedent-cancer-lineage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacologic-prevention-of-radiotherapy-induced-nausea-and-vomiting-network-meta-analysis-includin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinicogenomic-comparison-of-early-and-average-onset-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-esophageal-cancer-mortality-in-south-asia-a-retrospective-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-differences-in-advanced-gynecological-cancers-after-the-development-of-immune-checkpoint-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-multi-level-interventions-on-immunohistochemistry-uptake-in-breast-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-feasibility-study-of-apricitycarefor-early-detection-and-management-of-immune-related-adverse-even 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-disparities-in-surveillance-adherence-among-individuals-with-idicer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-operation-of-contralateral-prophylactic-mastectomy-and-risk-reducing-salpingo-oophorectomy-in-kor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-locally-developed-referral-criteria-for-palliative-care-in-metastatic-hormone-recepto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-early-phase-oncology-trials-in-brazil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bronchoscopic-pulsed-electric-field-ablation-for-locally-advanced-and-metastatic-nsclc-a-six-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-triple-negative-breast-cancer-with-decreased-t-score-of-femoral-neck-at-the-time-of-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiomyopathy-mortality-among-us-adults-with-breast-cancer-a-25-year-cdc-wonder-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-risk-in-cystic-fibrosis-systemic-review-and-quantitative-synthesis-of-epidemiolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-nasopharyngeal-carcinoma-in-a-20-year-retrospective-cohort-from-a-lower-middl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-with-olutasidenib-after-venetoclax-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/point-of-care-cancer-screening-using-saliva-transmission-spectroscopy-and-machine-learning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-patterns-and-survival-outcomes-in-acute-myeloid-leukemia-with-t69p23q34-dek-nup21 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adalimumab-on-mortality-and-cancer-risk-in-patients-with-inflammatory-diseases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-skin-cancer-prevention-and-early-detection-behaviors-in-syria-a-cross-sectional-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-expansion-of-home-phlebotomy-with-type-and-screen-testing-for-hematologic-monitoring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-clinicopathologic-factors-and-immune-repertoire-sequencing-to-optimize-decision-making-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-treatment-modality-and-recurrence-in-non-metastatic-leiomyosarcoma-a-retrospective-cohort-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-level-trends-and-geographic-disparities-in-pancreatic-cancer-mortality-among-individuals 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-of-non-oncologic-interventions-for-neoplastic-fever 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-palliative-care-consultation-and-end-of-life-care-intensity-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-cancer-susceptibility-genes-in-metastatic-lung-cancer-a-hong-kong-territory-wide-genomic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physics-informed-neural-network-driven-early-assessment-of-peg-feeding-tube-placement-prediction-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-and-systematic-review-of-cardiac-adverse-events-in-patients-with-her2-altered-non-sm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemotherapy-or-preoperative-chemoradiotherapy-in-patients-with-esophageal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-therapeutic-response-to-neoadjuvant-chemotherapy-in-breast-carcinoma-in-a-low-middle-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aumolertinib-as-first-line-therapy-for-locally-advanced-or-metastatic-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recognition-and-management-patterns-of-cachexia-in-patients-with-pancreatic-adenocarcinoma-in-a-safe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-cell-free-chromatin-state-kinetics-as-a-predictor-of-early-treatment-response-in-gastric-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/screen-failure-and-treatment-dropout-in-oncology-clinical-trials-a-multicenter-analysis-from-turki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-racial-disparities-in-diffuse-large-b-cell-lymphoma-mortality-in-the-united-stat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-access-disruptions-in-mexico-real-world-delivery-irregularities-at-a-public-cancer-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paclitaxel-carboplatin-and-durvalumab-in-extensive-stage-small-cell-lung-cancer-es-sclc-ifct-220 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-dm005-an-anti-egfrc-met-bispecific-antibody-drug-conjugate-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-immunotherapy-and-molecular-diagnostics-for-lung-adenocarcinoma-in-syria-a-mixed-methods 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omic-ctdna-based-mrd-for-predicting-clinical-outcomes-in-advanced-nsclc-receiving-chemoimmunot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-bgb-a3055-anti-ccr8-with-or-without-tislelizumab-anti-pd-1-in-patients-with-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/two-cycle-versus-three-cycle-induction-chemotherapy-followed-by-concurrent-chemoradiotherapy-in-loco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-man1a1-to-address-immune-checkpoint-inhibitors-resistance-a-novel-mechanism-of-vascular-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-housing-instability-as-a-quality-of-care-determinant-in-cancer-a-meta-analysis-across-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-hrqol-with-neoadjuvant-and-adjuvant-neoadj-adj-enfortumab-vedotin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-perceived-caregiver-burden-after-intense-oncology-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-odronextamab-odro-plus-chemotherapy-chop-in-diffuse-large-b-cell-lymphoma-dlbcl-ol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mediterranean-cd19-genetic-variations-and-potential-influence-on-car-t-cell-therapy-efficacy-implic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-on-treatment-for-systemic-therapies-for-patients-with-hormone-receptor-positive-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-by-lymphomap-archetypes-in-untreated-diffuse-large-b-cell-lymphoma-from-the-polarix-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ikmt2ci-mutation-to-identify-an-immunotherapy-sensitive-subset-of-gastroint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-multiplex-digital-profiling-of-dna-methylation-heterogeneity-to-enable-sensitive-early-detect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evidence-of-clonal-stability-in-a-5-year-longitudinal-prospective-cohort-of-cancer-survivors-with-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-inrasi-and-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-methylation-subtypes-as-a-predictor-of-clinical-outcome-to-immunotherapy-in-pleural-mesothelio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-ceralasertib-atr-inhibitor-plus-durvalumab-in-patients-with-advanced-gastric-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-iterative-cannabis-care-plans-with-rates-of-symptom-relief-and-side-effect-burden-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-imiquimod-treatment-outcomes-in-vulvar-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-trends-in-rural-patient-enrollment-in-swog-cancer-clinical-trials-1992-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-health-equity-in-oncology-virtual-collaborative-behavioral-health-engagement-and-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telehealth-visits-to-support-extended-dosing-of-pembrolizumab-and-reduce-health-care-visits-a-pragm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individualized-estimation-of-benefit-from-adjuvant-docetaxel-plus-s-1-in-stage-iii-gastric-cancer-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ace-inhibitors-acei-and-angiotensin-receptor-blockers-arb-on-outcomes-in-hepatocellula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-tumor-characteristics-and-clinical-impact-of-ilztr1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-gemcis-immunotherapy-vs-fgfr-inhibition-in-ctdna-detected-ifgfr2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modulation-of-pd-1-and-pd-l1-expression-on-peripheral-blood-t-cells-by-novel-rotavirus-variants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-presurgical-circulating-tumor-dna-ctdna-levels-with-pathologic-p-stage-and-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-study-of-tumor-informed-ctdna-minimal-residual-disease-detection-in-bone-and-soft-tiss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-prophylactic-cranial-irradiation-and-brain-surveillance-in-limited-stage-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-evaluation-of-machine-learning-optimization-strategies-for-uveal-melanoma-detection-using 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd103-supsup-cd8-supsup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glix1-a-first-in-class-oral-molecule-targeting-the-dna-damage-response-by-restoring-tet2-activity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-preferences-for-duration-of-adjuvant-trastuzumab-for-her2-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-outcomes-of-osimertinib-based-treatment-in-a-phase-iii-study-comparing-egfr-tyrosine-kinas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-trial-on-the-safety-tolerance-and-preliminary-efficacy-of-intracavitary-injection-of-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-historical-response-rates-a-meta-analysis-of-kras-g12c-inhibitors-in-pretreated-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/smoking-genomic-discordance-in-metastatic-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-related-disparities-and-survival-in-high-grade-glioma-a-social-vulnerability-analysis-at-a-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-phase-ii-clinical-study-of-different-time-delivered-drugs-combined-with-intensity-modu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-risk-and-benefit-of-adjuvant-therapy-in-stage-ib-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-relatlimab-nivo-rela-in-advanced-melanoma-5-year-update-of-relativity-047 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-larotrectinib-in-patients-with-non-primary-central-nervous-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-mortality-in-hospitalized-patients-with-metastatic-non-small-cell-lung-cancer-mnsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-olaparib-with-versus-without-bevacizumab-in-bevacizumab-naive-brca12-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-pancreatic-cancer-in-the-united-states-1991-2021-temporal-trends-geographic-variatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-lung-cancer-in-systemic-lupus-erythematosus-patients-with-interstitial-lung-disease-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-repeat-next-generation-sequencing-in-patients-with-driver-negative-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-and-tolerability-of-the-selective-ret-inhibitor-soxataltinib-sy-5007-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-and-prognostic-factors-with-adjuvant-pembrolizumab-for-renal-cell-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-clearance-durability-and-progression-free-survival-in-unresectable-or-metastatic-cutaneous-mal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-multi-omics-biomarkers-to-predict-benefit-from-immune-checkpoint-inhibitors-in-biliary-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gemini-nsclc-multiomics-and-single-cell-spatial-profiling-to-benchmark-back-translate-and-build-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cigarette-smoking-on-outcomes-with-osimertinib-in-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-breast-density-are-convolutional-neural-networks-the-only-path 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-prolonged-versus-shorter-duration-pembrolizumab-following-chemoradiation-in-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stk11-andor-keap1-alterations-in-kras-mutant-nsclc-treated-with-immune-checkpoint-inhibitors-or-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-heterogeneity-of-metastatic-patterns-in-prostate-cancer-relative-to-bone-only-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-incidence-of-infections-and-cytopenias-in-bcma-vs-gprc5d-targeting-bispecific-antibodie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-ikrasi-mutations-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-mortality-following-intracranial-hemorrhage-in-patients-with-brain-metastases-from-melan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-testing-of-an-ex-vivo-live-tumor-fragment-platform-for-the-prediction-of-immune-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-biomarkers-for-truce-01-development-of-a-urine-based-efficacy-prediction-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/larynx-preservation-via-chemotherapy-free-neoadjuvant-sintilimab-cetuximab-sbrt-and-response-adapted 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-outcome-among-adolescents-in-canada 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-l1-upregulation-as-a-reflection-of-distinct-immune-contexts-in-luminal-and-basal-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-an-artificial-intelligence-based-management-model-on-psychological-and-behavioral-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-kmt2-family-mutations-to-define-a-distinct-epithelial-high-stromal-depleted-and-interferon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-management-and-outcomes-of-adolescents-and-young-adults-with-myeloproliferative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-of-olverembatinib-hqp1351-as-second-line-therapy-in-patients-with-chro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-nucleosome-and-genomic-signatures-as-predictors-of-outcomes-with-radium-223-in-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-radiologically-identified-embryological-origin-on-recurrence-patterns-and-survival-in-rese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-palliative-care-gaps-in-young-adult-ovarian-cancer-a-population-based-study-of-37880 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-survival-outcome-in-clinical-stage-ii-iii-non-small-cell-lung-cancer-undergoing-neoadj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-local-treatments-for-oligoprogressive-or-oligorecurrent-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-by-immunotherapy-agent-of-real-world-outcomes-with-chemoimmunotherapy-in-first-line-exten 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-of-day-of-immune-checkpoint-inhibitor-infusion-on-clinical-outcomes-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-aspires-study-promoting-colorectal-cancer-surveillance-in-childhood-cancer-survivors-a-randomiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-risk-factors-of-individuals-ineligible-for-lung-cancer-screening-at-a-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-diabetes-on-respiratory-infection-risk-and-hospitalization-following-immune-checkpoint-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-patient-and-product-specific-phenotypes-associated-with-toxicity-and-resource-utilization-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-elranatamab-as-early-intervention-in-patients-with-high-risk-smoldering-myelo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-long-term-outcomes-in-prostate-cancer-mortality-survival-and-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evidence-supporting-irps20i-as-a-colorectal-cancer-susc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-month-versus-six-month-duration-of-postoperative-adjuvant-therapy-after-r0-resection-following 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pdlim2-expression-and-characteristics-in-kras-mutated-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-high-grade-neuroendocrine-carcinoma-hgnec-biology-across-tumor-types-through-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-t-dxd-versus-anti-trop2-adcs-therapy-in-her2-low-advanced-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-in-silico-prioritization-of-tumor-associated-antigen-pairs-to-support-bispecific-antibod 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-analysis-of-molecules-targeting-regulatory-t-cells-in-patients-with-oral-squamous-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-adding-stereotactic-radiosurgery-to-dual-immune-checkpoint-blockade-in-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-poor-performance-status-on-outcomes-with-immune-checkpoint-inhibitors-in-advanced-non-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-neoadjuvant-immune-checkpoint-blockade-icb-for-resectable-stage-iii-melanom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immunotherapy-infusion-timing-on-overall-and-progression-free-survival-in-advanced-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-and-mechanism-of-cmtm6-in-radiosensitivity-of-breast-cancer-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-and-outcomes-of-hematopoietic-stem-cell-transplantation-in-testicular-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-survival-outcomes-of-immune-checkpoint-inhibitors-in-metastatic-lung-cancer-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-phase-i-therapeutic-landscape-in-pancreatic-ductal-adenocarcinoma-molecular-profiling-and-emerg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-results-and-prognosis-analysis-of-tpf-regimen-chrono-chemotherapy-combined-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-thyroid-cancer-mortality-among-adults-in-the-united-states-and-puerto-rico-1999-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-in-de-novo-versus-metachronous-metastatic-breast-cancer-across-molecular-subtypes-a-large 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-pd-1-failure-in-advanced-melanoma-real-world-outcomes-with-lenvatinib-based-versus-non-lenvati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-a-randomized-phase-ii-trial-of-chidamide-plus-fulvestrant-with-or-without-sin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-operative-management-versus-nonoperative-care-for-cancer-associated-small-bowel-obstruction-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-autoantibodies-and-treatment-outcomes-in-metastatic-melanoma-treated-with-anti-pd-1-or-ipil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-ed-utilization-for-oncologic-neutropenic-and-non-neutropenic-fever-through-an-urgent-care-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-pembrolizumab-and-nivolumab-as-first-line-treatment-for-advancedunrese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-sex-specific-symptom-based-predictors-of-lung-cancer-risk-using-explainable-machine-lear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hpv-vaccination-initiation-and-completion-among-sexual-minority-women-in-california 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-concurrent-chemoradiotherapy-versus-chemoradiotherapy-alone-in-locoregion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-distribution-of-antibody-drug-conjugate-adc-associated-adverse-events-aes-in-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-derived-tumor-burden-and-growth-rate-as-translational-biomarkers-head-to-head-comparison-with-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-sidedness-and-social-determinants-of-health-on-survival-in-early-onset-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dying-tumor-cells-as-a-driver-of-tumor-repopulation-after-insufficient-thermal-ablation-of-papillary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-and-health-related-social-needs-in-adolescent-and-young-adult-cancer-patients-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-pharmacokinetic-study-of-high-dose-vitamin-c-dosing-regimens-in-patients-with-advanced-hepat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-cardio-oncology-care-gap-in-india-real-world-guideline-adherence-and-ai-driven-workflo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-nc410-and-folfirinox-in-combination-with-nivolumab-with-or-without-ipilimumab-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpath-013-a-phase-2-randomized-double-blind-study-of-intismeran-autogene-plus-pembrolizumab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-adjuvant-therapy-on-survival-in-gastric-cancer-patients-achieving-pathologic-complete 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-impacts-of-stomatitis-and-related-lesions-on-clinical-outcomes-in-lung-cancer-patients-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malnutrition-as-associated-with-high-risk-airway-failure-phenotypes-in-hospitalized-head-and-neck-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-phase-ibii-study-of-neoadjuvant-zolbetuximab-plus-docetaxel-oxaliplatin-and-s-1-dos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/care-utilization-and-inpatient-mortality-among-women-younger-than-50-years-hospitalized-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rise-trial-a-novel-virtually-delivered-supervised-exercise-intervention-targeting-cognitive-impairm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-clinical-trial-in-progress-of-z-endoxifen-plus-goserelin-as-neoadjuvant-therapy-in-preme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ttfields-with-maintenance-temozolomide-tmz-and-pembrolizumab-versus-ttfields-with-maintenance-tmz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-review-of-representation-in-clinical-trials-for-metastatic-prostate-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-as-a-surrogate-for-overall-survival-in-ovarian-cancer-real-world-evidence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-and-clinical-associations-of-rare-co-mutations-in-ira 2026-08-24 monthly 0.7 https://rjrindex.com/articles/propel-capturing-the-lived-experience-of-lung-cancer-for-patients-and-caregivers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rare-forms-of-endometrial-cancer-growth-factor-levels-in-tumor-tissue-and-patient-serum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-and-practice-toward-hereditary-lung-cancer-in-brazil-a-gbot-grupo-brasileiro-de-oncologi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cachexia-as-an-inpatient-vulnerability-phenotype-in-lung-cancer-a-national-inpatient-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-hypofractionated-radiotherapy-on-pathologic-response-in-locally-advanced-cervical-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individualized-neoantigen-therapy-intismeran-autogene-intismeran-plus-pembrolizumab-pembro-in-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-markers-of-response-and-toxicity-to-tarlatamab-in-patients-with-extensive-stage-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/us-patient-enrollment-in-pivotal-clinical-trials-that-supported-fda-oncology-approvals-from-2020-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-subgroup-analyses-for-prior-taxane-use-in-the-phase-3-rosella-trial-of-relacorilant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/izalontamab-brengitecan-iza-bren-versus-chemotherapy-in-patients-with-recurrent-or-metastatic-esop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effects-of-mediterranean-diet-physical-activity-and-vitamin-d-on-breast-cancer-recurrence-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mandibular-preservation-with-neoadjuvant-tislelizumab-plus-platinum-doublet-chemotherapy-in-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-trial-of-olaparib-and-pembrolizumab-vs-olaparib-alone-as-maintenance-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-a-phase-2-trial-of-ssgj-707-pf-08634404-a-pd-1vegf-bispecific-antibody-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-utilization-and-end-of-life-care-in-pancreatic-cancer-a-single-institution-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lipid-reprogramming-as-driver-of-statin-targetable-vulnerability-in-early-onset-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-interrupting-hospitalization-as-an-acute-oncologic-toxicity-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-events-in-patients-with-mismatch-repair-deficient-gynecologic-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contrast-free-virtual-enhancement-multi-modal-deep-learning-synthesis-of-cect-from-pct-and-mri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/representation-of-rural-oncology-practices-in-quality-certification-programs-insights-from-qopi-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structured-oncologist-appraisal-of-ai-generated-clinical-literature-summaries 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-care-utilization-and-management-patterns-of-asymptomatic-incidental-pulmonary-embolism-in-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-nationwide-genetic-counsellors-survey-insights-to-plan-a-scalable-framework-for-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-the-pre-malignant-niche-in-cholangiocarcinoma-a-single-cell-multi-omic-atlas-from-inflamma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sars-cov-2-associated-epstein-barr-virus-reactivation-and-lymphomagenesis-a-systematic-review-and-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-e7386-phase-1-trials-for-cardiac-safety-gaining-concentration-qtc-insights-to-inform-ear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-trends-hospital-volume-and-drivers-of-survey-weighted-30-day-unplanned-readmission-afte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-and-clinicopathologic-characterization-of-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ranking-neoantigens-for-escape-resilience-rather-than-predicted-immunogenicity-associated-changes-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-tissue-free-molecular-residual-disease-assay-in-colorectal-breast-and-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-tarlatamab-in-extensive-stage-small-cell-lung-cancer-at-an-academic-cente 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-effects-of-t-cell-senescence-in-rcc-and-hgsoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-evaluation-and-preclinical-mechanistic-studies-of-targeted-hyperthermia-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-study-of-osimertinib-and-tegavivint-as-first-line-therapy-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-with-grade-4-idh-mutant-astrocytomas-the-ut-md-anderson-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-multi-omics-profiling-of-the-primary-lung-microenvironment-to-elucidate-the-mechanism-of-oss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reframing-access-to-innovative-oncology-medicines-the-impact-of-policy-and-governance-reform-in-a-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-and-rural-urban-patterns-in-pediatric-and-aya-malignant-brain-tumor-mortality-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survivorship-focused-content-at-the-american-society-of-clinical-oncology-asco-2022-2024-annual-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-and-survival-outcomes-of-hispanic-patients-with-germ-cell-tumors-at-a-multihospital-academic-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-neoadjuvant-chemoimmunotherapy-chemoio-versus-pd-l1-monotherapy-mono-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-gemini-pro-for-primary-site-prediction-in-a-real-world-blinded-cohort-of-465-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-indirect-comparison-of-egfr-tki-combination-therapies-in-advanced-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structured-exercise-program-following-adjuvant-chemotherapy-for-colon-cancer-a-cost-utility-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitors-in-advanced-non-small-cell-lung-cancer-a-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-marrow-metastasis-in-prostate-cancer-treatment-feasibility-and-survival-in-a-real-world-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-and-predictive-utility-of-peritoneal-tumor-dna-in-gastroesophageal-cancer-a-prospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-cancer-organoids-20-in-precision-cancer-medicine-patient-derived-pancreatic-ductal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-utidelone-plus-fruquintinib-for-the-treatment-of-platinum-resistant-recurrent-ovar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-apobec-like-signature-in-diffuse-large-b-cell-lymphoma-and-demonstration-of-distinct-transc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-following-car-t-cell-therapy-in-relapsed-or-refractory-multiple-myeloma-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-a-modified-geriatric-assessment-to-identify-impairments-in-adults-of-all-ages-with-lympho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-supportive-care-in-malignant-bowel-obstruction-a-qi-project-using-virtual-dietitian-led-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-non-randomized-phase-iii-study-of-sentinel-node-navigation-surgery-for-early-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experiences-with-a-multi-cancer-detection-mcd-blood-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-evaluation-of-the-psychological-impact-of-multicancer-early-detection-mced-blood-testi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-intervention-strategies-to-improve-follow-up-after-fitfobt-tests-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-analysis-from-a-multicenter-randomized-phase-2-investigator-initiated-etctn-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/closing-the-gap-in-germline-testing-in-patients-with-cancer-through-a-clinic-based-awareness-initiat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-use-and-survival-by-demographic-and-socioeconomic-factors-in-primary-central-nervous-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pd-1-inhibitor-plus-chemotherapy-vs-chemotherapy-alone-in-advanced-gastric-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-and-preliminary-correlative-analysis-of-a-phase-i-study-of-anetumab-ravtansine-in-comb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bxcl701-plus-pembrolizumab-in-second-line-advanced-pancreatic-ductal-adenocarcinoma-final-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-sys6010-an-egfr-antibody-drug-conjugate-adc-in-patients-with-advanced-esophagea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-prognostic-models-for-mortality-prediction-after-unplanned-hospitalization-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-sbrt-with-gm-csf-and-peg-ifna-to-induce-abscopal-effects-in-previously-treated-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-associations-of-cannabis-use-among-patients-receiving-immune-checkpoint-inhibitors-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-in-hospital-outcomes-of-multiple-myeloma-in-autoimmune-rheumatic-disease-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-chemotherapy-for-pancreatic-cancer-in-an-integrated-healthcare-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-cancer-patients-undergoing-molecular-residual-disease-testing-with-a-tumor-inform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-clinical-genomic-and-survival-outcomes-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/upfront-surgery-versus-neoadjuvant-chemotherapy-in-resectable-pancreatic-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-lung-adenocarcinoma-incidence-among-younger-adults-in-the-united-states-a-seer-based-join 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-silico-phase-iii-clinical-trial-of-avelumab-plus-axitinib-versus-sunitinib-in-advanced-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-prognostic-value-of-claudin-182-expression-in-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-focused-analyses-of-the-impact-of-circadian-rhythm-on-efficacy-of-first-line-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matching-adjusted-indirect-comparison-maic-for-belantamab-mafodotin-belamaf-with-pomalidomide-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-systemic-therapy-followed-by-surgery-for-synchronous-liver-metastases-from-pancreatic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/residual-cancer-burden-after-neoadjuvant-therapy-in-lung-cancer-a-single-institution-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-after-single-fraction-preoperative-stereotactic-radiosurgery-for-brain-metastases-a-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-an-ehr-facilitated-symptom-surveillance-intervention-on-rehabilitation-utilization-in-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-inpatient-chemotherapy-in-central-nervous-system-cns-tumors-predictors-treatment-patterns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-for-prediction-of-postoperative-pulmonary-embolism-after-lung-cancer-surgery-using 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delivering-oncology-care-in-syria-implementation-lessons-from-conflict-affected-and-resource-limite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-transcriptomic-signatures-to-predict-treatment-outcomes-across-targeted-and-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myeloablative-vs-reduced-intensity-conditioning-in-ptcy-based-allogeneic-hct-a-cibmtr-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adjuvant-immunotherapy-after-pathologic-complete-response-to-neoadjuvant-chemo-immunothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-aging-within-the-tumor-microenvironment-as-a-predictor-of-survival-in-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-profiling-in-advanced-hepatocellular-carcinoma-to-identify-biomarkers-for-immunothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-expansion-and-dose-optimization-study-of-cx-5461-in-patients-with-solid-tumours-enriched-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-equity-in-precision-oncology-impact-of-in-house-ngs-for-nsclc-in-a-safety-net-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-barriers-to-fra-directed-therapy-integration-in-platinum-resistant-ovarian-cancer-a-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leukemia-mortality-in-latin-america-and-the-united-states-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-opioid-related-hospitalizations-among-adult-cancer-patients-2000-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-changes-in-immune-checkpoint-and-cell-populations-following-lymphodepletion-and-car-t-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distribution-and-density-of-tertiary-lymphoid-structures-as-predictors-of-clinical-outcomes-and-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sting-agonist-jmkx000197-infusion-in-patients-with-malignant-pleural-effusion-preliminary-results-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-the-role-of-locoregional-radiotherapy-for-de-novo-metastatic-nasopharyngeal-carcinoma-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-analysis-of-ctdna-methylation-based-histology-prediction-and-associated-clinical-charac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-imaging-models-for-predicting-immune-checkpoint-inhibitor-response-in-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-ii-trial-of-encorafenib-binimetinib-and-cetuximab-for-early-relapsed-stage-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-from-the-adjuvant-ado-trastuzumab-emtansine-t-dm1-for-older-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-social-marginalization-on-stage-at-presentation-and-survival-for-invasive-lobular-versus-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-early-implementation-of-a-statewide-comprehensive-childhood-cancer-network-to-suppor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utopia-a-phase-3-trial-of-ugn-103-an-intravesical-mitomycin-reverse-thermal-hydrogel-in-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-trial-of-fruquintinib-plus-capecitabine-versus-capecitabine-alone-as-maintenan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-blood-based-cfdna-fragmentomic-assays-for-lung-cancer-detection-a-meta-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-de-escalation-of-implant-based-breast-reconstruction-ibbr-after-mastectomy-for-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-toripalimab-and-chemotherapy-for-organ-preservation-in-locally-advanced-laryngeal-and-hypo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-breast-malignancies-in-adolescents-and-young-adults-the-md-anderson-cancer-center-experienc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-definitive-chemoradiotherapy-following-neoadjuvant-chemoimmunotherapy-in-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-hpv16-specific-viral-immunotherapy-hb200-plus-chemotherapy-with-response-adapted-de-es 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-or-rescue-disitamab-vedotin-for-high-risk-non-muscle-invasive-bladder-cancer-with-her2-over 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-single-arm-phase-ii-trial-evaluating-the-safety-and-efficacy-of-panitumumab-and-irinot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-of-shr-1501-an-il-15rafc-superagonist-with-or-without-bacille-calmette 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neo-adjuvant-radiation-and-intratumoral-immunotherapy-followed-by-surgery-the-naris-trial-for-extre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nonoperative-management-of-locally-advanced-resectable-cutaneous-squamous-cell-cancer-of-the-head-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-landscape-and-outcomes-of-black-and-white-adults-diagnosed-with-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamics-of-circulating-monomeric-c-reactive-protein-mcrp-to-predict-outcomes-with-first-line-alte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hma-plus-venetoclax-for-7-vs-14-vs-21-vs-28-day-cycles-in-newly-diagnosed-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hopemove-feasibility-and-acceptability-of-a-mobile-exercise-app-for-pediatric-patients-undergoing-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-for-characterizing-intratumor-heterogeneity-and-outcomes-in-metastatic-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-infiltration-features-relative-to-cancer-cell-clumps-as-predictors-of-survival-in-triple-nega 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-preservation-and-local-excision-for-rectal-cancer-long-term-oncologic-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-genomic-alterations-between-local-breast-cancers-and-cutaneous-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-malignancy-on-cardiac-complications-and-mortality-in-patients-with-covid-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fixed-duration-glofitamab-monotherapy-in-relapsedrefractory-rr-mantle-cell-lymphoma-mcl-withw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-concomitant-antibiotic-exposure-on-overall-survival-in-patients-with-esophagogastric-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-treatment-tx-duration-in-patients-pts-with-metastatic-hormone-sensitive-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frontline-intensified-vs-standard-immunochemotherapy-in-high-risk-diffuse-large-b-cell-lymphoma-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-and-genomic-landscape-of-pancreatic-acinar-cell-carcinoma-a-single-center-experie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-oncology-data-paradigm-in-practice-a-feasibility-study-of-structured-data-capture-with-minimal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-rna-sequencing-approach-for-isoform-detection-of-dpep1-in-colorectal-cancer-and-in-vitro-characte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimally-invasive-versus-open-esophagectomy-for-resectable-esophageal-cancer-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/to-rechallenge-or-not-to-rechallenge-immune-checkpoint-inhibitor-associated-neurotoxicity-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accuracy-and-consensus-strategies-for-large-language-model-abstraction-of-axillary-surgery-type-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-androgen-deprivation-therapy-and-the-androgen-receptor-ligand-directed-degrader 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-methods-forward-indirect-comparison-of-io-io-versus-io-vegf-as-first-line-therapy-for-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-neoadjuvant-nivolumab-relatlimab-versus-nivolumab-in-patients-with-resectable-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-microbiota-dynamics-of-antibiotic-fecal-microbiota-transplantation-in-esophageal-and-gastric-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-accrual-speed-in-us-phase-iii-therapeutic-cancer-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-treatment-patterns-and-outcomes-of-patients-aged-80-years-with-aggressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/importance-of-where-you-die-lung-cancer-mortality-trends-in-homeless-proxy-settings-across-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/presenting-and-therapy-related-psychiatric-manifestations-of-metastatic-and-primary-brain-tumors-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-and-predictive-role-of-fdg-petct-in-melanoma-patients-treated-with-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-tarlatamab-outcomes-and-safety-in-a-global-multicenter-electronic-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-on-the-correlation-between-gut-microbiota-and-metabolite-brevifolincarboxylic-acid-and-liver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-including-levetiracetam-with-standard-treatment-in-glioblastoma-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-among-patients-with-metastatic-non-small-cell-lung-cancer-mnsclc-who-received-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-pcsk9-inhibition-in-small-cell-lung-cancer-with-novel-dll3-targeted-bispecif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-adjuvant-carboplatin-based-chemotherapy-in-stage-i-triple-negative-breast-cancer-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-tils-spatial-analysis-to-identify-high-density-hot-spots-as-a-superior-prognostic-marker-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-ikrasi-atlas-of-9056-chinese-patients-subt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-artificial-intelligence-on-inter-reader-variability-in-breast-ultrasound-interpretation-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomized-study-comparing-bcd-201-a-pembrolizumab-biosimilar-candidate-and-reference 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-adjuvant-nivolumab-and-survival-outcomes-in-bladder-cancer-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-modal-molecular-profiling-of-cdh1-and-cldn182-to-identify-predictive-biomarkers-for-zolbetuxi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-feasibility-of-68ga-dotatate-petct-to-identify-sstr-positive-soft-tissue-sarcoma-for-prrt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-pathology-amplified-risk-understanding-outcomes-in-tls-with-concurrent-heart-failure 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-the-dna-plasmid-based-vaccine-stemvac-in-patients-with-metastatic-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-hospital-complications-and-outcomes-of-autologous-stem-cell-transplantation-in-diffuse-large-b-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/noleeta-no-chemotherapy-in-intermediate-risk-hr-her2-early-breast-cancer-treated-with-ribociclib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/origami-5-a-randomized-phase-3-study-of-amivantamab-plus-pembrolizumab-and-carboplatin-vs-standard 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interception-of-molecular-relapse-in-breast-cancer-the-survive-heroes-study-nct06643585 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-study-of-ateganosine-thio-6-thio-2-deoxyguanosine-sequenced-with-immune-checkpoint-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuroendocrine-tumors-real-world-evidence-from-a-national-cancer-institute-in-panama 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protocol-for-adhere-a-randomised-controlled-trial-evaluating-a-digital-exercise-intervention-with-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-cell-receptor-tcr-repertoire-dynamics-of-response-to-neoadjuvant-chemo-immunotherapy-in-triple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-a-first-in-class-prmt1-inhibitor-cts2190-in-patients-pts-with-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/behavioral-gains-offset-by-metabolic-drift-a-34-year-global-profile-of-breast-cancer-risk-attributi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/attention-driven-vision-transformer-analysis-for-automated-melanoma-diagnosis-using-dermoscopy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-social-needs-screening-in-community-oncology-settings-results-from-the-wf-2303cd-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-the-tumor-cardiovascular-mortality-in-female-ovarian-cancer-patients-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-incidence-and-clinical-outcomes-of-trastuzumabpertuzumab-induced-thrombocytopenia-in-adj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/10-year-molecular-landscape-of-metastatic-colorectal-cancer-in-latin-america-gender-and-age-specifi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-based-second-generation-immunotherapy-bc1-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-surgery-refusal-and-disease-specific-survival-outcomes-in-inflammatory-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-pd-l1-expression-with-tertiary-lymphoid-structure-maturity-and-immune-cell-spatial-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-patterns-of-hospitalization-mortality-and-resource-utilization-in-merkel-cell-carcinoma-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/locally-advanced-or-metastatic-thyroid-cancer-treated-with-donafenib-with-or-without-chemotherapy-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-medicaid-expansion-on-five-year-mortality-among-patients-with-melanoma-in-the-united-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-priorities-for-a-digital-health-platform-to-support-lynch-syndrome-surveillance-and-research 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opportunities-for-lung-cancer-screening-a-prospective-cross-sectional-study-of-patients-with-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-escalation-in-the-elderly-adjuvant-fluoropyrimidine-monotherapy-vs-oxaliplatin-based-regimens-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-lung-cancer-from-2000-to-2023-and-projections-to-2035-implications-for-ctdna-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-for-non-metastatic-colorectal-cancer-in-nigeria-a-10-year-retrospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engineering-and-evaluating-intelligent-information-retrieval-systems-for-hepatocellular-carcinoma-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-selective-estrogen-receptor-degrader-monotherapy-versus-standard-endocrine-therapy-in-estrogen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-electronic-patient-navigation-platform-to-enhance-adjuvant-therapy-coordination-af 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-use-and-adherence-to-breast-cancer-clinical-practice-guidelines-among-brazilian-medical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-differences-by-treatment-setting-in-older-adults-with-classical-hodgkin-lymphoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-intensive-induction-with-73-plus-midostaurin-versus-azacitidine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-brentuximab-vedotin-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-evaluating-liposomal-irinotecan-combined-with-capecitabine-as-second-line-therapy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-in-patients-with-hepatobiliary-and-pancreatic-cancers-taking-glp-1-receptor-agonist-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-neoadjuvant-radiotherapy-combined-with-surgery-on-long-term-prognosis-of-patients-with-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-survival-benefit-with-treatment-at-academic-cancer-programs-in-older-adults-with-ptcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-specific-comparative-effectiveness-of-locoregional-therapies-in-early-stage-hepatocellular-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-prophylactic-fibrin-glue-on-post-gastric-esd-bleeding-in-gastric-neoplasm-a-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resection-and-intracranial-implant-of-z-ini-butylid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intersecting-risks-myelodysplastic-neoplasms-and-cardiovascular-disease-mortality-in-older-adults-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-high-risk-human-papillomavirus-infection-in-allogeneic-stem-cell-transplant-recipients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-baseline-18f-fdg-petct-in-first-line-pembrolizumab-plus-chemotherapy-for-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecularly-defined-subgroups-within-ras-wt-mcrc-treatment-selection-and-overall-survival-in-projec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-factors-affecting-diagnostic-delay-in-patients-referred-to-the-pediatric-oncology-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variations-in-ambient-airborne-carcinogen-concentrations-particulate-matter-pm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-sepsis-related-mortality-among-decedents-with-malignant-neoplasms-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-the-global-cancer-research-funding-by-public-and-philanthropic-investments-address-important-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-leukapheresis-and-pharmacologic-cytoreduction-in-hyperleukocytosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metabolic-health-and-risk-of-early-onset-cancers-in-obese-young-adults-real-world-insights-from-a-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-delivery-and-exposure-of-aldoxorubicin-compared-with-doxorubicin-integrated-clinical-and-prec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-study-between-neoadjuvant-hormone-therapy-plus-cdk-46-inhibitors-versus-neoadjuvant-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-emr-prompts-to-promote-equitable-clinical-trial-participation-in-gynecologic-oncology-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dreamm-9-final-analysis-belantamab-mafodotin-belamaf-bortezomib-lenalidomide-and-dexamethasone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-kinetics-throughout-first-line-ai-and-palbociclib-using-a-tumor-informed-structural-variant-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-qlc5508-mhb088c-in-heavily-treated-patients-with-metastatic-castration-resi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-combined-with-toripalimab-for-cisplatin-refractory-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/wait-or-treat-managing-asymptomatic-brain-metastases-in-oncogene-mutated-nsclc-results-of-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-nesuparib-jpi-547-with-gemcitabine-nab-paclitaxel-gemabraxane-or-modified 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imforte-quality-adjusted-time-without-symptoms-or-toxicity-q-twist-analysis-of-first-line-mainten 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-operative-ctdna-detected-molecular-residual-disease-in-resected-non-small-cell-lung-cancer-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-contemporary-treatments-including-immunotherapy-for-poorly-differentiated-neu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chrono-chemotherapy-combined-with-imrt-in-locoregionally-advanced-nasopharyngeal-carcinoma-a-prospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-circulating-tumor-cell-synaptophysin-and-androgen-receptor-expression-in-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-the-association-between-new-onset-depression-and-outcomes-in-metastatic-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lycopene-and-survival-in-patients-with-stage-iii-colon-cancer-findings-from-calgb-allianceswog-8 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dll3-targeted-therapy-with-tarlatamab-in-small-cell-lung-cancer-across-lines-of-therapy-a-systemati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reassessing-obesity-and-smoking-as-renal-cell-carcinoma-risk-factors-trinetx-2016-2025-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erythropoietin-receptor-epor-expression-as-an-independent-prognostic-biomarker-in-clear-cell-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drivers-of-organotropism-and-patterns-of-metastatic-progression-in-metastatic-non-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emotional-burnout-among-oncology-clinicians-in-russia-results-of-a-national-cross-sectional-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characterization-of-patients-with-molecular-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-changes-in-pulmonary-function-following-multiple-courses-of-thoracic-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burned-out-lymph-nodes-in-testicular-cancer-a-new-entity-in-imaging-and-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-observation-of-growth-and-pubertal-development-following-car-t-cell-therapy-for-children 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neurotoxicity-in-immune-checkpoint-inhibitor-associated-myositis-with-elevated-soluble-il-2-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-social-media-listening-of-oncologist-conversations-at-asco-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-matched-adjusted-indirect-comparison-maic-of-nogapendekin-alfa-inbakicept-pmln-plus-bacillus-cal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histomics-as-an-emerging-avenue-for-oncology-biomarker-development-computational-histology-artifici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/two-dimensional-mathematical-modeling-of-tumor-invasion-using-the-generalized-integral-transform-tec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pkci-yap1-ccl7-axis-and-tumor-associated-macrophage-mediated-anti-pd-1-resistance-in-lung-adenocarci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keratin-19-krt19-as-a-circulating-biomarker-to-measure-disease-burden-and-guide-treatment-in-uroth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multiple-instance-learning-based-deep-learning-model-with-multi-channel-input-for-early-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-opportunistic-risk-model-to-predict-pancreatic-cancer-risk-using-pre-diagnostic-contrast-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-duet-1-trial-feasibility-and-toxicity-outcomes-and-early-oncological-outcomes-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-patients-with-multiple-myeloma-through-the-insist-program-outcomes-of-biomarker-testing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-and-racial-disparities-in-palliative-care-utilization-and-end-of-life-outcomes-in-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-covid-19-severity-on-the-local-lung-hormonal-profile-in-patients-with-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-differences-in-early-vs-late-onset-pancreatic-cancer-a-retrospective-cohort-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-feasibility-and-usability-study-of-a-virtual-exercise-platform-in-patients-with-non-small-cell-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-pembrolizumab-in-clear-cell-renal-cell-carcinoma-with-high-recurrence-risk-a-multicenter-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-subsequent-line-strategies-for-iegfri-mutant-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-self-efficacy-and-symptom-burden-in-young-women-with-breast-cancer-initiating-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-cfdna-and-nets-with-dnase-i-to-augment-car-t-cell-function-and-antitumor-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lost-in-translation-evaluating-associations-between-english-proficiency-and-next-generation-sequenc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-implementation-of-remote-geriatric-assessment-guided-supportive-care-gain-s-in-pub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/representing-peoples-experience-of-cancer-and-its-treatment-respect-pilot-study-a-global-collabo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-multimodal-thermal-therapy-combined-with-immune-checkpoint-inhibitors-and-chemotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-cancer-drug-revenue-retained-by-providers-under-buy-and-bill-reimbursement-2010-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-overall-survival-in-lung-adenocarcinoma-real-world-results-from-three-french-nationwide-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-deployment-of-a-multimodal-artificial-intelligence-ai-model-for-predicting-response-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-signature-hrdsig-in-clinically-advanced-gallbladder-adenocarcinoma-cagac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-single-cell-trajectory-analysis-and-machine-learning-to-build-a-robust-prognostic-classif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-itp53i-mutated-clonal-hematopoies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/screening-and-trends-a-global-burden-of-disease-2023-assessment-of-colorectal-cancer-mortality-acro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutation-landscape-and-pathway-level-disparities-in-black-versus-white-patients-with-acute-myeloid-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-velzatinib-idrx-42-in-patients-with-advancedmetastatic-gist-by-line-of-therapy-and-ci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-immune-checkpoint-inhibitors-in-elderly-colorectal-cancer-patients-in-the-real-world-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-diabetes-associated-cancer-mortality-in-the-united-states-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/should-cdk46-inhibitor-plus-endocrine-therapy-be-standard-of-care-for-er-low-1-10-hrher2-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-cumulative-cost-of-preventive-surveillance-versus-treatment-in-li-fraumeni-syn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-facility-type-and-surgical-management-on-survival-outcomes-in-colon-adenocarcinoma-stratif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-various-radiation-therapy-options-on-plasminogen-activation-markers-in-the-blood-of-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-healthcare-resource-utilization-hcru-following-chimeric-antigen-receptor-car-t-cell-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-spin-score-a-simple-clinical-score-to-predict-pain-response-following-celiac-plexus-radiosurger 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-medicaid-expansion-with-pre-diagnosis-coverage-continuity-and-2-year-overall-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-izalontamab-si-b001-in-combination-with-paclitaxel-or-docetaxel-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-prognostically-relevant-residual-tumor-burden-in-glioblastoma-after-surgery-a-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-outcomes-and-risk-of-second-primary-malignancy-spm-in-patients-with-multiple-myeloma-mm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multichannel-deep-learning-network-for-predicting-survival-in-stage-i-nsclc-patients-treated-with-sb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-protein-energy-malnutrition-with-mortality-resource-utilization-and-discharge-dispo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brigatinib-after-lorlatinib-andor-chemotherapy-following-first-line-alectinib-in-alk-rearranged-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-parsimonious-fitbit-step-metrics-to-improve-frailty-classification-in-adults-50-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-insights-into-bone-marrow-carcinomatosis-in-metastatic-breast-cancer-a-retrospective-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-recruitment-of-ayas-with-hodgkin-lymphoma-through-community-partnerships-prioritizing-div 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-comorbidity-discordance-and-non-relapse-mortality-after-allogeneic-hematopoietic-cell-transp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longer-term-safety-of-pimicotinib-in-tenosynovial-giant-cell-tumor-tgct-integrated-analysis-of-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/untargeted-baseline-metabolomic-profiling-to-identify-candidate-markers-of-long-term-severe-cancer-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-iesr1i-amplification-with-survival-and-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disco-update-diagnostic-performance-of-sup64sup-cu-sar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonist-for-primary-prevention-of-hepatocellular-carcinoma-in-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-impact-of-community-knowledge-and-shared-support-on-the-iegfr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-combined-with-temozolomide-and-fluoxetine-for-newly-diagnosed-grade-4-glioma-prelimina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-from-malignant-neoplasms-of-digestive-system-and-renal-failure-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-medically-tailored-meals-plus-nutrition-counseling-on-treatment-adherence-in-vulnerable-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-tumor-activity-of-man-9-x-ps-targeting-immunotherapies-in-diffuse-intrinsic-pontine-glioma-dip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-baicalein-and-oxaliplatin-co-loaded-nano-delivery-system-for-dual-gasdermin-mediated-pyroptosis-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-oncology-navigation-based-on-epros-effects-on-acute-healthcare-utilization-and-cost-savings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-combined-with-lenvatinib-and-gemcitabine-plus-cisplatin-in-advanced-biliary-tract-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-telepalliative-care-and-end-of-life-outcomes-in-advanced-cancer-a-multicenter-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-with-addition-of-inotuzumab-ozogamicin-to-hcvad-and-sequential-blinatumomab-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-macroeconomic-burden-of-cancer-global-disparities-in-value-of-lost-welfare-vlw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-microenvironment-phenotypes-and-survival-in-fibrolamellar-carcinoma-an-exploratory-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-signature-based-risk-score-for-parp-inhibitor-response-in-ibrcai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-trial-of-anti-cldn182pd-l1-recombinant-humanized-bispecific-antibody-q-1802-plus-xelox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-of-mirdametinib-in-combination-with-sirolimus-for-patients-with-ras-mutated-relap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-survival-disparities-and-future-incidence-projections-of-small-intestine-neuroendocri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-antibody-drug-conjugates-in-hrher2-advanced-breast-cancer-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-associated-with-five-star-online-reviews-of-oncologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolution-of-the-therapeutic-landscape-in-metastatic-uveal-melanoma-a-single-institution-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-inflammatory-indexes-and-prognosis-for-progression-free-survival-in-first-line-pembrolizuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extracapsular-dissection-vs-superficial-parotidectomy-for-pleomorphic-adenomas-of-parotid-gland-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uptake-of-screening-breast-mri-in-high-risk-patients-without-a-personal-history-of-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-study-of-adebrelimab-for-immune-resumption-after-immune-related-adverse-events-iraes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/major-adverse-cardiovascular-events-during-elective-chemotherapy-admissions-incidence-predictors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethno-religious-inequities-in-clinical-presentation-and-survivorship-outcomes-in-breast-cancer-a-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-activity-of-trastuzumab-deruxtecan-in-her2-low-breast-cancer-with-brain-metastases-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-associated-myocarditis-outside-of-immunotherapy-national-burden-and-inpatient-outcomes-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-alk-tyrosine-kinase-inhibitors-in-alk-positive-non-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-optimization-in-fda-oncology-drug-approvals-factors-associated-with-observing-exposure-efficac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-lung-cancer-and-atrial-fibrillationflutter-related-mortality-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-patient-outcomes-in-a-safety-net-healthcare-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-long-term-follow-up-non-respondence-in-a-prospective-study-of-financial-toxicity-of-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-smarca4-deficiency-to-tumor-agnostic-therapies-a-single-center-retrospective-study-for-66-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-of-patients-with-cancer-of-unknown-primary-cup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ncdb-analysis-on-the-demographic-treatment-and-survival-of-ovarian-papillary-mucinous-cystadeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-tumor-informed-ctdna-detection-and-dynamics-in-a-real-world-cohort-of-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncosegue-transforming-cancer-care-delivery-through-a-decentralized-community-integrated-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-ki-67cd34-prognostic-model-for-risk-stratification-in-resected-gastrointestinal-stromal-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prediction-nomogram-for-perioperative-deep-vein-thrombosis-risk-in-breast-cancer-patients-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-and-meta-analysis-evaluating-role-of-ai-ml-and-dl-based-models-for-predictin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-breast-cancer-related-mortality-with-thoracic-involvement-among-us-adults-aged-25-yea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osimertinib-in-the-treatment-of-egfr-mutation-positive-advanced-non-small-cell-lung-cancer-a-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distribution-of-braf-functional-classes-across-select-tumor-lineages-with-implications-in-current-ta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-gap-recognizing-the-inequities-in-oncology-research-and-clinical-practice-guidelines-an-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neoadjuvant-immunotherapy-on-safety-of-axillary-de-escalation-in-triple-negative-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allostatic-load-and-myosteatosis-in-women-with-metastatic-breast-cancer-at-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiance-predictive-score-a-new-model-of-radiological-markers-for-prediction-of-antiangiogenics-eff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-conditional-survival-analysis-of-blastic-plasmacytoid-dendritic-cell-neoplasm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-initial-systemic-staging-imaging-workup-for-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chidamide-combined-with-serplulimab-and-regorafenib-or-fruquintinib-as-third-line-therapy-for-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-study-of-first-line-immunotherapy-for-egfralk-wild-type-advanced-nsclc-analysis-from-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-vs-human-based-frameworks-for-breast-cancer-molecular-biomarker-status-asses 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-healthcare-burden-of-penile-cancer-in-people-living-with-hiv-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/renal-safety-and-clinical-outcomes-of-enfortumab-vedotin-plus-pembrolizumab-in-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop2-as-an-actionable-biomarker-for-anal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-of-immune-checkpoint-inhibitor-chemotherapy-regimens-across-multiple-tumor-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-psa-kinetics-and-depth-of-response-with-arpi-based-triplet-therapy-in-metastatic-hormone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-trial-of-the-tead-inhibitor-odm-212-in-patients-with-advanced-solid-tumors-teades 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-mevrometostat-m-in-combination-with-enzalutamide-e-in-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bytes-to-blood-artificial-intelligence-in-leukemia-management-a-2025-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/generalized-integral-transform-technique-gitt-in-tumor-dynamics-a-technical-qualitative-review-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduced-intensity-versus-intensive-induction-in-high-risk-acute-promyelocytic-leukemia-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-abiraterone-in-metastatic-prostate-cancer-a-multicenter-study-in-peru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disproportionate-reporting-of-ischemic-gastrointestinal-injury-associated-with-lenvatinib-a-faers-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-older-adults-with-advanced-thyroid-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cetuximab-in-combination-with-immunotherapy-and-chemotherapy-as-preoperative-induction-therapy-for-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-ripretinib-on-the-pharmacokinetics-pk-of-midazolam-mdz-a-sensitive-cyp3a-probe-substr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/natural-language-processing-nlp-to-identify-neoplastic-fever-in-the-electronic-medical-record-emr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/competing-risks-of-relapse-and-major-organ-failure-after-allogeneic-hematopoietic-cell-transplantati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-hair-loss-associated-with-brentuximab-vedotin-containing-chemotherapy-and-its-psychosocial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlates-of-alcohol-related-cancer-risk-awareness-in-us-adults 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-characteristics-of-somatic-itp53i-mut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-the-influence-of-node-positivity-and-advanced-clinical-stage-on-response-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-liver-cancer-mortality-among-adults-with-metabolic-disorders-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcome-planning-and-reporting-in-car-t-and-cd3xcd20-bispecific-antibody-trials-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sedative-hypnotic-use-peri-chemotherapy-and-short-term-fall-and-fracture-risk-in-older-adults-with-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-impact-of-ga-informed-re-evaluation-of-multidisciplinary-tumor-board-plans-in-thoracic-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-liver-cancer-mortality-due-to-hepatitis-b-in-south-asia-a-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-preferences-regarding-bispecific-antibody-bsab-treatment-schedules-and-clinical-profiles-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/s2433-randomized-phase-iii-study-of-second-line-chemotherapy-with-or-without-panitumumab-for-kras-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoradiotherapy-plus-sintilimab-versus-chemoradiotherapy-as-neoadjuvant-treatment-in-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-drug-induced-pneumonitis-from-trastuzumab-deruxtecan-in-patients-with-advanced-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triple-switch-swogcctg-pr26-a-randomized-phase-iii-clinical-trial-for-the-addition-of-docetaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-survival-outcomes-of-liver-cancer-in-a-tertiary-oncology-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predict-rd-postoperative-molecular-residual-disease-by-ctdna-surveillance-in-tnbc-with-residual-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-body-radiotherapy-plus-cadonilimab-and-lenvatinib-as-conversion-therapy-for-potentially 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-unscheduled-oncologic-consultations-at-a-tertiary-center-in-north-africa-are-we-treatin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-transcriptomic-profiling-and-explainable-machine-learning-to-reveal-functional-reprogramm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-cancer-incidence-and-mortality-of-children-adolescents-and-young-adults-in-hong-kong-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scrambler-therapy-for-painful-chemotherapy-induced-peripheral-neuropathy-extending-the-evidence-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-metformin-on-clinically-significant-chemotherapy-induced-peripheral-neuropathy-a-systemat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/substance-use-disorders-following-cancer-diagnosis-in-adolescents-and-young-adults-a-canadian-popul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-neutrophil-to-lymphocyte-ratio-dynamics-during-cabozantinib-therapy-in-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-rates-for-upper-gastrointestinal-cancers-as-a-cause-or-contributing-factor-in-adults-aged 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-safety-and-biodistribution-of-sup68sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanidatamab-chemotherapy-ct-tislelizumab-for-first-line-1l-her2-positive-her2-locally-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-placebo-controlled-trial-of-b-cell-depletion-for-prevention-of-corticosteroid-requiring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-burden-in-ayas-global-and-us-trends 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-translational-results-from-the-phase-1-portion-of-the-phase-12-study-to-evaluate-chm-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-county-level-factors-of-oncology-fellowship-program-development-from-2015-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-injection-of-ip-001-following-thermal-ablation-in-patients-with-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-succinate-dehydrogenase-b-protein-expression-in-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revisiting-the-role-of-immune-checkpoint-inhibitor-based-combination-therapies-in-favorable-risk-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-recurrence-and-survival-in-hormone-receptor-positive-hrher2-negative-her2-early-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-pharmacokinetics-of-xnw28012-a-tissue-factor-antibody-drug-conjugate-adc-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/g8-screening-defined-geriatric-vulnerability-as-a-predictor-of-survival-and-quality-of-life-in-older 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-immune-checkpoint-inhibitor-therapy-in-patients-with-pre-existing-autoimmune-disease-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-injectable-medication-uptake-among-united-states-cancer-survivors-with-diabe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-based-differences-in-in-hospital-outcomes-among-hospitalized-patients-with-lung-cancer-receiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-active-controlled-phase-3-study-of-ivonescimab-folfox-versus-bevacizumab-folfox-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concept-combination-of-cetuximab-plus-fruquintinib-treatment-immunotherapy-a-multicenter-rando 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-efficacy-of-venetoclax-combination-therapies-versus-obinutuzumab-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-mass-index-on-toxicity-and-outcomes-after-cd19-directed-car-t-therapy-for-non-hodgkin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avatar-efficacy-of-personalized-tumorogram-based-therapy-in-breast-cancer-established-from-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peak-1-a-randomized-double-blind-active-control-multicenter-phase-3-trial-of-casdatifan-and-cabo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-ds3610-a-stimulator-of-interferon-genes-sting-agonist-antibody 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-clio-8221-a-her2-targeted-dual-payload-exatecan-and-atr-inhibitor-antibody-drug 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zolbetuximab-in-cldn182-positive-biliary-tract-cancer-after-prior-systemic-therapy-a-prospective-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-outcomes-of-older-adult-patients-on-enfortumab-vedotin-for-urothelial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-sdoh-and-barriers-to-allogeneic-hematopoietic-stem-cell-transplantat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-in-endometrial-cancer-a-multi-center-initiative-to-standardize-biomarker-testing-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutational-signatures-as-potential-predictors-of-hipec-response-and-recurrence-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-multicenter-phase-iv-study-to-evaluate-the-efficacy-and-safety-of-sonide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-mapping-of-fibroblast-subtypes-in-primary-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-line-of-therapy-selection-methods-in-advanced-non-small-cell-lung-cancer-ansclc-a-simul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thyroid-cancer-risk-in-systemic-lupus-erythematosus-a-population-based-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-her2-targeted-therapy-with-pyrotinib-plus-inetetamab-and-adebrelimab-in-previously-treated-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-melanoma-in-syria-a-retrospective-analysis-from-the-national-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-and-on-treatment-dynamics-of-ibrafi-v600e-circ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proton-pump-inhibitor-use-and-overall-survival-in-patients-with-gastric-adenocarcinoma-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endocrine-adverse-events-associated-with-immunotherapy-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-primary-tumor-location-on-treatment-and-outcomes-in-ewing-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tirzepatide-induced-lipid-metabolic-remodeling-in-relation-to-clonogenicity-and-migration-in-colorec 2026-08-24 monthly 0.7